期刊文献+

结肠系膜混合型Castleman病一例

下载PDF
导出
摘要 Castleman病是一种临床上罕见的反应性慢性淋巴组织增殖性疾病,又被称为血管滤泡性淋巴组织增生症、巨大淋巴结病或血管瘤性淋巴样错构瘤。目前为止,该病的病因及发病机制尚不清楚。由于其病理学及影像学检查、临床表现等缺乏特异性,该病的误诊率较高。现报道1例结肠系膜混合型Castleman病,以加深对此病的认识。1临床资料患者,男,22岁,因查体“发现腹腔肿瘤6 d”于2022年10月6日入院。一般检查:未见异常。CT:腹腔占位,考虑Castleman病,请结合临床及其他检查。MRI(平扫+强化):腹腔肠系膜区见一类圆形软组织影,截面约43 mm×34 mm,边界尚清,T1WI稍低信号,T2WI/DWI稍高信号,增强后呈持续强化,动脉期内见粗大血管影。初诊:Castleman病可能性大,不除外胃肠道间质瘤。
出处 《山东医学高等专科学校学报》 2024年第1期95-97,共3页 Journal of Shandong Medical College
基金 山东省自然科学基金(No.ZR2021MH033)。
  • 相关文献

参考文献5

二级参考文献38

  • 1Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:427
  • 2Seo S,Yoo C,Yoon DH,et al. Clinical features and outcomes in patients with human immunodeficiency virus-negative,multicentric Castleman’s disease:a single medical center experience[J].Blood Res,2014,49(4):253-258.
  • 3Kawabata H,Kadowaki N,Nishikori M,et al. Clinical features and treatment of multicentric castleman’s disease:a retrospective study of 21 Japanese patients at a single institute[J]. J Clin Exp Hematop,2013,53(1):69-77.
  • 4Dispenzieri A,Armitage JO,Loe MJ,et al. The clinical spectrum of Castleman’s disease[J]. Am J Hematol,2012,87(11):997-1002.
  • 5Casper C,Teltsch DY,Robinson D Jr,et al. Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease[J].Br J Haematol,2015,168(1):82-93.
  • 6van Rhee F,Wong RS,Munshi N,et al. Siltuximab for multicentric Castleman’s disease:a randomised,double-blind,placebo-controlled trial[J]. Lancet Oncol,2014,15(9):966-974.
  • 7Nishimoto N,Kanakura Y,Aozasa K,et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease[J].Blood,2005,106(8):2627-2632.
  • 8Leger-Ravet MB,Peuchmaur M,Devergne O,et al. Interleukin-6 gene expression in Castleman’s disease[J]. Blood,1991,78(11):2923-2930.
  • 9Fajgenbaum DC,van Rhee F,Nabel CS. HHV-8-negative,idiopathic multicentric Castleman disease:novel insights into biology,pathogenesis,and therapy[J]. Blood,2014,123(19):2924-2933.
  • 10Stone K,Woods E,Szmania SM,et al. Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman disease and is associated with increased soluble interleukin-6 receptor levels[J]. PLoS One,2013,8(1):e54610. doi:10.1371/journal.pone.0054610.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部